RecruitingNCT05056857

Neutrophil Extracellular Traps Formation in Breast Cancer Patients Taking Tamoxifen

Studying Twin-reversed arterial perfusion sequence

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
M.D. Anderson Cancer Center
Principal Investigator
Jyotika Sharma
M.D. Anderson Cancer Center
Intervention
Biospecimen Collection(procedure)
Enrollment
290 target
Eligibility
18 years · FEMALE
Timeline
20212026

Study locations (1)

Collaborators

National Cancer Institute (NCI) · National Institute of Allergy and Infectious Diseases (NIAID)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05056857 on ClinicalTrials.gov

Other trials for Twin-reversed arterial perfusion sequence

Additional recruiting or active studies for the same condition.

See all trials for Twin-reversed arterial perfusion sequence

← Back to all trials